Chandrani Mukherjee
Acadia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chandrani Mukherjee.
Bioorganic & Medicinal Chemistry Letters | 2010
Amitabh Jha; Chandrani Mukherjee; Ashok K. Prasad; Virinder S. Parmar; Manjula Vadaparti; Umashankar Das; Erik De Clercq; Jan Balzarini; James P. Stables; Anuraag Shrivastav; Jonathan R. Dimmock
Several series of compounds containing the 1,4-dioxo-2-butenyl moiety have been prepared as candidate cytotoxins, including the methyl N-arylmaleamates, methyl N-arylfumaramates, and N-arylmaleimides. In addition, the N-arylisomaleimides were synthesized which are the structural isomers of N-arylmaleimides. These compounds were evaluated against human Molt 4/C8 and CEM T-lymphocytes as well as murine L1210 cells. Methyl N-arylfumaramates showed the highest cytotoxic potencies and, in particular, methyl N-(3,4-dichlorophenyl)fumaramate is six times more potent than melphalan towards L1210 cells and is equipotent with this drug in the Molt 4/C8 assay. Electrophilicity of compounds under investigation was demonstrated by carrying out thiolation using model benzyl mercaptan on representative compounds. Methyl N-(3,4-dichlorophenyl)fumaramate and methyl N-(4-chlorophenyl)maleamate inhibited human N-myristoyltransferase, a possible molecular target, in high micromolar range. QSAR and molecular modeling revealed some correlations between different structural features of a number of the molecules and cytotoxic potencies. Methyl N-arylfumaramates were well tolerated in mice in comparison to the analogs in other series of compounds tested. The data obtained in this investigation affords guidelines for preparing new series of molecules with greater potencies.
Pure and Applied Chemistry | 2005
Poonam; Ashok K. Prasad; Chandrani Mukherjee; Gaurav Shakya; Gautam K. Meghwanshi; Jesper Wengel; Rajendra Kumar Saxena; Virinder S. Parmar
Different (±)-4-(3/4-acetoxyaryl)-5-ethoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2-ones have been synthesized and subjected to enantioselective deacetylation reactions mediated by different lipases in organic media. Novozyme 435 in tetrahydrofuran:diisopropyl ether was found to be the catalyst of choice for efficient enantioselective deacetylation of dihydropyrimidinones under study. Further, we discovered that lipase isolated from Pseudomonas aeruginosa can be used for selective acylation of secondary hydroxyl groups in nucleosides. This observation can be very useful for selective manipulation of different hydroxyl groups in nucleosides.
Biochemistry | 2005
Sarvesh Kumar; Pragya Arya; Chandrani Mukherjee; Brajendra K. Singh; Naresh Singh; Virinder S. Parmar; Ashok K. Prasad; Balaram Ghosh
Bioorganic & Medicinal Chemistry | 2006
Anil Kumar Chhillar; Pragya Arya; Chandrani Mukherjee; Pankaj Kumar; Yogesh Yadav; Ajendra K. Sharma; Vibha Yadav; Jyotsana Gupta; Rajesh Dabur; Hirday N. Jha; Arthur C. Watterson; Virinder S. Parmar; Ashok K. Prasad; Gainda L. Sharma
Bioorganic & Medicinal Chemistry | 2007
Amitabh Jha; Chandrani Mukherjee; Ashok K. Prasad; Virinder S. Parmar; Erik De Clercq; Jan Balzarini; James P. Stables; Elias K. Manavathu; Anuraag Shrivastav; Kurt H. Nienaber; Gordon A. Zello; Jonathan R. Dimmock
Bioorganic & Medicinal Chemistry Letters | 2007
Amitabh Jha; Chandrani Mukherjee; Alfred J. Rolle; Erik De Clercq; Jan Balzarini; James P. Stables
Journal of Molecular Catalysis B-enzymatic | 2010
Chandrani Mukherjee; Erin D. MacLean; T. Stanley Cameron; Amitabh Jha
Synlett | 2007
Amitabh Jha; Po-Jung Jimmy Huang; Chandrani Mukherjee; Nawal K. Paul
Journal of Molecular Catalysis B-enzymatic | 2006
Ashok K. Prasad; Chandrani Mukherjee; Deepti Sharma; Soumya Rastogi; Anshuman Mangalam; Amitabh Jha; Carl Erik Olsen; Shamkant Anant Patkar; Virinder S. Parmar
Journal of Molecular Catalysis B-enzymatic | 2006
Ashok K. Prasad; Chandrani Mukherjee; Sunil K. Singh; Raju Brahma; R. K. Singh; Rajendra Kumar Saxena; Carl Erik Olsen; Virinder S. Parmar